Comparing Patient-Reported Outcomes Among Anti-TNF-Experienced Patients with Crohn's Disease Initiating Vedolizumab Versus Ustekinumab
Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.
Full Citation
Kappelman MD, Lewis JD, Zhang X, Lin FC, Weisbein L, Chen W, Burris J, Dorand JE, Parlett LE, Haynes K, Nair V, Kaul AF, Dobes A, Long MD. Comparing Patient-Reported Outcomes Among Anti-TNF-Experienced Patients with Crohn's Disease Initiating Vedolizumab Versus Ustekinumab. Dig Dis Sci. 2023 Apr 28. doi: 10.1007/s10620-023-07942-0. Epub ahead of print. PMID: 37115362.
Tags
Has Results
- Has Results
Journal Article Type
- Paper Resulting From PCORI-Funded Research Study conducted using PCORnet® (with results)
- CER Results
Journal Publication Name
- Digestive Diseases and Sciences
Literature Type
- PCORI Research